Panniculitis induced by a chemotherapy regimen consisting of topotecan and cyclophosphamide.
Kismet
Erol
E
Demirkaya
Erkan
E
Koseoglu
Vedat
V
Deveci
Salih
S
Atay
Abdullah Avni
AA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D008297:Male; D015080:Mesna / Q000008:administration & dosage / Q000494:pharmacology; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy*; D015434:Panniculitis / Q000139:chemically induced* / Q000473:pathology; D019772:Topotecan / Q000008:administration & dosage / Q000009:adverse effects*
D019772:Topotecan; D003520:Cyclophosphamide; D015080:Mesna